Weizmann Institute of Science
Dr. Novick was born in Poland in 1948, a daughter to two Auschwitz and death march survivors. In 1957 her family immigrated to Israel, where in 1967, she served in the Israeli air force. Dr. Novick received an M.S. in Microbiology in 1972 from Tel-Aviv University and in 1973 was a Research Assistant in the Department of Medicine, University of Cambridge, England. Dr. Novick received her Ph.D. in 1979 from The Weizmann Institute of Science, Rehovot, Israel and holds the position of tenured Senior Staff Scientist in the Department of Molecular Genetics. In 1979, she and Dr. Rubinstein generated a battery of monoclonal antibodies to IFN-Î±, -Î² and -Î³, which was a pioneering achievement at that time.
Since 1987, in the laboratory of Dr. Rubinstein, Dr. Novick’s research focuses on cytokines and their receptors. Dr. Novick’s work has been translated into clinically useful therapies, and her research expertise made a major contribution to the isolation and development of IFN-beta and tumor necrosis factor soluble receptor p75, each of which has reduced the severity of multiple sclerosis and rheumatoid arthritis for hundreds of thousands of patients.